Fenofibrate Trial Aims to Prevent Worsening of Diabetic Retinopathy
A randomized trial is evaluating fenofibrate's efficacy in preventing worsening of diabetic retinopathy over 6 years.
Company
Pharmaceutical intelligence for pharma companies in ophthalmology with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No signals indexed for this entity yet.
No signals indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.